Best Health News

Advertisers



Recent comments

Who's online

There are currently 0 users and 2 guests online.
Home

Monkey trial may show possible way to AIDS vaccine

Quality (59)
Helpful (64)
WASHINGTON (Reuters) - A shot that helps keep AIDS-infected monkeys alive may offer the best clues yet about how to make an effective HIV vaccine, researchers reported on Thursday.
Technorati Tags:
Submitted by root on Thu, 2006-06-08 18:23.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Filtered words will be replaced with the filtered version of the word.
  • Lines and paragraphs break automatically.
  • You can use Textile markup to format text.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img>
More information about formatting options

Similar entries

  • Future seen promising for AIDS vaccine
    TORONTO (Reuters) - There is no vaccine against AIDS and none of the dozens of vaccines being tested is likely to completely protect people from the deadly virus, but the future looks bright for AIDS vaccine development, researchers said on Tuesday.
  • Future promising for AIDS vaccine: group
    TORONTO (Reuters) - There is no vaccine against AIDS and none of the dozens of vaccines being tested is likely to completely protect people from the deadly virus, but the future looks bright for AIDS vaccine development, researchers said on Tuesday.
  • Trial of H5N1 vaccine effective in low doses
    LONDON (Reuters) - Low doses of an experimental Chinese vaccine against the H5N1 bird flu virus produce an immune response in healthy people, according to early trial results reported on Thursday.
  • Scientists take step toward obesity vaccine
    WASHINGTON (Reuters) - A vaccine that slows down a key hunger hormone kept rats from gaining weight, even when they over ate, U.S. researchers reported on Monday.
  • Intercell vaccine has positive results in trial
    VIENNA (Reuters) - Austrian biotech firm Intercell's Japanese Encephalitis virus vaccine, due to be launched in 2007, was well tolerated by patients in a clinical trial, the company said on Thursday.
  • Merck's cervical cancer vaccine wins US approval
    WASHINGTON (Reuters) - The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. shot to block a sexually transmitted infection that causes the deadly disease.
  • AIDS no longer killing all patients: study
    WASHINGTON (Reuters) - More than a quarter of New Yorkers infected with the AIDS virus are now dying of other causes, researchers said on Monday.
  • AIDS no longer killing all patients, study finds
    WASHINGTON (Reuters) - More than a quarter of New Yorkers infected with the AIDS virus are now dying of other causes, researchers said on Monday.